Scarica l'app Stockscreener
3.83
4.25%
-0.17
Dopo l'orario di chiusura:
3.84
0.010
+0.26%
Larimar Therapeutics Inc Borsa (LRMR) Ultime notizie
A Deeper Dive Into Design Therapeutics (NASDAQ:DSGN) - Seeking Alpha
Larimar Therapeutics Inc (LRMR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Larimar Therapeutics Inc (LRMR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LRMR|Larimar Therapeutics Inc|Price:3.820|Chg%:-0.180 - TradingKey
Enterprise value to EBITDA forward of Larimar Therapeutics, Inc. – NASDAQ:LRMR - TradingView
TradingKey - TradingKey
Larimar Therapeutics Market Sentiment - Benzinga España
Larimar Therapeutics, Inc. Revenue Breakdown – NASDAQ:LRMR - TradingView
What Just Happened with Larimar Therapeutics (LRMR) and Why Does it Matter - Kavout | AI
LRMR|Larimar Therapeutics Inc|Price:4.000|Chg%:-0.010 - TradingKey
Larimar Therapeutics Inc (LRMR) Institutional Confidence - TradingKey
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc.LRMR - PR Newswire
LifeSci Capital Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Price to earnings forward of Larimar Therapeutics, Inc. – SWB:ZA71 - TradingView
Larimar Therapeutics Files First Module of BLA for Nomlabofusp in Friedreich's Ataxia TreatmentNew Analyst Coverage - dars.gov.et
Larimar Therapeutics Initiates BLA Submission for Nomlabofusp in Friedreich’s AtaxiaProfit Guidance Range - dars.gov.et
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy - Yahoo Finance
Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? - Stocktwits
Price to earnings forward of Larimar Therapeutics, Inc. – LS:A2P5PP - TradingView
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy - Stocktwits
Price to sales forward of Larimar Therapeutics, Inc. – NASDAQ:LRMR - TradingView
Thomas Hamilton Bought 6.1% More Shares In Larimar Therapeutics - Moomoo
Larimar Therapeutics stock jumps on insider purchase By Investing.com - Investing.com South Africa
Larimar Therapeutics stock jumps on insider purchase - Investing.com
Larimar Therapeutics director buys $166,890 in company stock - Investing.com UK
Enterprise value to revenue forward of Larimar Therapeutics, Inc. – SWB:ZA71 - TradingView
LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000 - TradingView
Larimar Therapeutics director buys $166,890 in company stock By Investing.com - Investing.com South Africa
Form 4 Larimar Therapeutics Inc For: 8 July By Investing.com - Investing.com Nigeria
symbol__ Stock Quote Price and Forecast - CNN
Larimar Therapeutics (LRMR) director purchases 50,000 common shares - Stock Titan
Law firm probes Larimar Therapeutics for possib... - Pluang
Larimar Starts FDA Filing for FA Drug With Mid-2027 Goal - MyChesCo
LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns - Stocktwits
Here’s What Citi Thinks About Larimar Therapeutics (LRMR) - Insider Monkey
H.C. Wainwright initiates Larimar stock coverage with buy rating - Investing.com UK
LRMR Assumed by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
H.C. Wainwright initiates Larimar stock coverage with buy rating By Investing.com - Investing.com South Africa
Larimar Therapeutics Coverage Assumed by HC Wainwright & Co. at Buy - Moomoo
Price to book forward of Larimar Therapeutics, Inc. – NASDAQ:LRMR - TradingView
H.C. Wainwright Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $10 - Moomoo
Larimar Therapeutics Up Nearly 32%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk - Moomoo
Citi Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's AtaxiaSlideshow (NASDAQ:LRMR) 2026-07-01 - Seeking Alpha
Enterprise value to EBIT forward of Larimar Therapeutics, Inc. – LS:A2P5PP - TradingView
Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - Moomoo
Here's Why We're Watching Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation - Moomoo
Wedbush Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $12 - Moomoo
LRMR Maintains by Baird -- Price Target Lowered to $5.00 - GuruFocus
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):